Solara Active Pharma Sciences Ltd Share Price Live

Add as a Preferred Source on Google
₹696.7
(7.38%)
Oct 16, 2026|03:59:16 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹648.8
  • Day's High₹759
  • 52 Wk High₹774
  • Prev. Close₹648.8
  • Day's Low₹645
  • 52 Wk Low ₹422
  • Turnover (lac)39,686.12
  • P/E0
  • Face Value₹10
  • Book Value₹263.01
  • EPS1.05
  • Mkt. Cap (Cr.)₹3,381.24
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Solara Active Pharma Sciences Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹648.8

Prev. Close

₹648.8

Turnover(Lac.)

₹39,686.12

Day's High

₹759

Day's Low

₹645

52 Week's High

₹774

52 Week's Low

₹422

Book Value

₹263.01

Face Value

₹10

Mkt Cap (₹ Cr.)

3,381.24

P/E

0

EPS

1.05

Divi. Yield

0

Solara Active Pharma Sciences Ltd Corporate Action

25 Aug 2026

12:00 AM

AGM

Announcement Date: 25 Aug, 2026

arrow

9 Oct 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Solara Active Pharma Sciences Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Solara Active Pharma Sciences Ltd SHAREHOLDING SNAPSHOT

18 Oct, 2026|03:46 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 41.93%

Foreign: 0.00%

Indian: 41.93%

Non-Promoter- 15.26%

Institutions: 15.26%

Non-Institutions: 42.80%

Custodian: 0.00%

Share PriceShare Price

Solara Active Pharma Sciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2026Mar-2025Mar-2024Mar-2023

Equity Capital

44.51

40.25

36

36

Preference Capital

0

0

0

0

Reserves

1,210.93

1,055.96

901.42

1,467.13

Net Worth

1,255.44

1,096.21

937.42

1,503.13

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

1,268.34

1,616.88

1,321.75

560.4

yoy growth (%)

-21.55

22.32

135.85

Raw materials

-653.89

-724.41

-598.87

-293.32

As % of sales

51.55

44.8

45.3

52.34

Employee costs

-234.2

-227.63

-202.24

-69.51

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

-88.17

220.96

112.49

1.95

Depreciation

-112.01

-108.31

-93.67

-36.55

Tax paid

33.1

0

0

0

Working capital

200.65

302.71

157.99

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-21.55

22.32

135.85

Op profit growth

-79.14

50.2

317.87

EBIT growth

-104.22

60.44

601.98

Net profit growth

-126.5

96.42

5,668.71

View Ratios
Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

1,368.98

1,283.76

1,288.92

1,443.81

1,268.34

Excise Duty

0

0

0

0

0

Net Sales

1,368.98

1,283.76

1,288.92

1,443.81

1,268.34

Other Operating Income

0

0

0

0

0

Other Income

6.16

8.32

5.37

22.55

20.02

Solara Active Pharma Sciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,758.8

132.684,22,426.911,115.140.915,641.3193.23

Divis Laboratories Ltd

DIVISLAB

9,144.5

80.112,39,982.278910.332,974629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,558.9

85.421,75,195.534920.734,073222.76

Zydus Lifesciences Ltd

ZYDUSLIFE

1,123

31.221,13,790.25339.60.092,723.5237.3

Laurus Labs Ltd

LAURUSLABS

2,060.1

125.081,09,143.07289.960.11,757.1697.2

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Solara Active Pharma Sciences Ltd

Management

Register Office

Registrar Office

Chairman & Independent Directo

Ramakrishnan Rajagopal

Independent Director

Kausalya Santhanam

Independent Director

Rajendra Kumar Srivastava

Independent Director

Rajiv Vijay Nabar

Non Executive Director

Arun Kumar Pillai

Non Executive Director

Manish Gupta

Managing Director & CEO

Sandeep Rao

ED / WTD / Chief Human Resources Officer

Mohanraj S

Company Sec. & Compli. Officer

Pooja Jaya Kumar

Registered Office

201 Devavrata Sector 17 Vashi,

Navi Mumbai,

Maharashtra - 400703

Tel: 91-22-27892924

Website: http://www.solara.co.in

Email: investors@solara.co.in

Registrar Office

Subramanian Building,

1ST Floor No 1, Club House Road,

Chennai - 600002

Tel: 91-44-28462700

Website: www.cameoindia.com

Email: investor@cameoindia.com

Summary

Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributi...
Read More

Reports by Solara Active Pharma Sciences Ltd

Company FAQs

The Solara Active Pharma Sciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹696.7 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Solara Active Pharma Sciences Ltd is ₹3381.24 Cr. as of 16 Oct ‘26
The PE and PB ratios of Solara Active Pharma Sciences Ltd is 0 and 2.52 as of 16 Oct ‘26
The 52-week high/low is the highest and lowest price at which a Solara Active Pharma Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Solara Active Pharma Sciences Ltd is ₹422 and ₹774 as of 16 Oct ‘26
Solara Active Pharma Sciences Ltd's CAGR for 5 Years at -13.04%, 3 Years at 27.12%, 1 Year at 11.80%, 6 Month at 31.75%, 3 Month at 12.33% and 1 Month at -9.36%.
The shareholding pattern of Solara Active Pharma Sciences Ltd is as follows:
Promoters - 41.93 %
Institutions - 15.26 %
Public - 42.81 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.